Edition:
United States

Xiangxue Pharmaceutical Co Ltd (300147.SZ)

300147.SZ on Shenzhen Stock Exchange

10.02CNY
26 May 2017
Change (% chg)

¥-0.11 (-1.09%)
Prev Close
¥10.13
Open
¥10.12
Day's High
¥10.18
Day's Low
¥9.99
Volume
5,679,800
Avg. Vol
6,000,125
52-wk High
¥16.11
52-wk Low
¥9.73

Latest Key Developments (Source: Significant Developments)

Xiangxue Pharmaceutical unit to buy Chongqing-based medical firm from co for 2.6 mln yuan
Friday, 28 Apr 2017 05:15am EDT 

April 28 (Reuters) - Xiangxue Pharmaceutical Co Ltd <300147.SZ> ::* Says co's 51 percent owned Beijing-based pharmaceutical biotech unit plans to fully buy co's Chongqing-based medical unit at 2.6 million yuan .  Full Article

Xiangxue Pharmaceutical unit to buy property in Wuhan at 167.3 mln yuan
Friday, 28 Apr 2017 05:10am EDT 

April 28 (Reuters) - Xiangxue Pharmaceutical Co Ltd <300147.SZ> ::* Says its unit enters into contract to buy a property (9574.05 square meter) located in Wuhan, at price of 167.3 million yuan .  Full Article

Xiangxue Pharmaceutical says no dividend for 2016
Tuesday, 28 Mar 2017 01:15am EDT 

Xiangxue Pharmaceutical Co Ltd <300147.SZ>:Says no dividend for 2016.  Full Article

Xiangxue Pharmaceutical issues 750 mln yuan super short-term debentures
Monday, 27 Mar 2017 10:36pm EDT 

Xiangxue Pharmaceutical Co Ltd <300147.SZ> :Says it issues 2017 first tranche super short-term debentures worth 750 million yuan with a term of 270 days and coupon rate of 5.6 percent.  Full Article

Xiangxue Pharmaceutical sees Q1 FY 2017 net profit down 20 pct to 40 pct
Sunday, 26 Mar 2017 11:53pm EDT 

Xiangxue Pharmaceutical Co Ltd <300147.SZ> : Sees Q1 FY 2017 net profit to decrease by 20 percent to 40 percent, or to be 18.9 million yuan to 25.2 million yuan . Says Q1 FY 2016 net profit was 31.5 million yuan .The reasons for the forecast are slowdown in medicine industry growth and increased financial expense.  Full Article

Xiangxue Pharmaceutical plans new units and to invest in two firms
Monday, 20 Mar 2017 11:48pm EDT 

Xiangxue Pharmaceutical Co., Ltd.<300147.SZ>: Says its Hubei-based Chinese medicine subsidiary plans to set up wholly owned Chinese medicine tech unit in Hubei, with investment of 5 million yuan . Says its Haozhou-based pharmaceutical subsidiary plans to set up wholly owned Chinese medicine unit in Jinan, with investment of 30 million yuan . Says its controlling medical investment management unit plans to use 10.5 million yuan to acquire 90 percent stake in Beijing-based bio-tech firm .Says the co plans to use 50 million yuan to acquire 10 percent stake in Shenzhen-based asset management firm, up from 0 percent.  Full Article

Xiangxue Pharmaceutical sees 2016 Q1~Q3 net profit to decrease by 35 pct to 50 pct
Friday, 14 Oct 2016 04:31am EDT 

Xiangxue Pharmaceutical Co Ltd <300147.SZ> :sees 2016 Q1~Q3 net profit to decrease by 35 percent to 50 percent, compared to net profit of Q1~Q3 in 2015(145.1 million yuan).  Full Article

Xiangxue Pharmaceutical issues 2016 1st tranche super short-term financing notes worth 750 mln yuan
Monday, 29 Aug 2016 01:45am EDT 

Xiangxue Pharmaceutical Co Ltd <300147.SZ> :Says it issues 2016 first tranche super short-term financing notes worth 750 mln yuan, with a term of 270 days and coupon rate of 3.39 percent.  Full Article

Xiangxue Pharmaceutical unit to set up Chinese medicine hospital management unit
Sunday, 14 Aug 2016 11:50pm EDT 

Xiangxue Pharmaceutical Co Ltd<300147.SZ>: Says its 70-percent-owned unit, Haozhou-based pharmaceutical company, plans to set up wholly owned unit in Haozhou .Says the new unit will be engaged in management of Chinese medicine hospital, with a registered capital of 50 million yuan.  Full Article

Xiangxue Pharmaceutical sees 2016 H1 net profit down 30 pct to 45 pct
Monday, 18 Jul 2016 09:13am EDT 

Xiangxue Pharmaceutical <300147.SZ>: Says net profit for 2016 H1 down 30 percent to 45 percent, or to be 51.2 million yuan to 65.1 million yuan .Says the net profit of 2015 H1 was 93.1 million yuan.  Full Article

More From Around the Web

BRIEF-Xiangxue Pharmaceutical unit to buy Chongqing-based medical firm from co for 2.6 mln yuan

* Says co's 51 percent owned Beijing-based pharmaceutical biotech unit plans to fully buy co's Chongqing-based medical unit at 2.6 million yuan